☰

Robert Cassell - Publications

Affiliations: 
2015- Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Meqbil YJ, Su H, Cassell RJ, Mores KL, Gutridge AM, Cummins BR, Chen L, van Rijn RM. Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland). 26. PMID 34885825 DOI: 10.3390/molecules26237236  0.689
2021 Sharma KK, Cassell RJ, Meqbil YJ, Su H, Blaine AT, Cummins BR, Mores KL, Johnson DK, van Rijn RM, Altman RA. Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. Rsc Medicinal Chemistry. 12: 1958-1967. PMID 34825191 DOI: 10.1039/d1md00025j  0.733
2021 Gutridge AM, Chakraborty S, Varga BR, Rhoda ES, French AR, Blaine AT, Royer QH, Cui H, Yuan J, Cassell RJ, Szabó M, Majumdar S, van Rijn RM. Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder. Frontiers in Pharmacology. 12: 764885. PMID 34803709 DOI: 10.3389/fphar.2021.764885  0.68
2019 Cassell RJ, Sharma KK, Su H, Cummins BR, Cui H, Mores KL, Blaine AT, Altman RA, van Rijn RM. The Meta-Position of Phe in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors. Molecules (Basel, Switzerland). 24. PMID 31842282 DOI: 10.3390/Molecules24244542  0.792
2019 Gutridge AM, Robins MT, Cassell RJ, Uprety R, Mores KL, Ko MJ, Pasternak GW, Majumdar S, van Rijn RM. G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder. British Journal of Pharmacology. PMID 31705528 DOI: 10.1111/Bph.14913  0.711
2019 Cai B, Kim D, Akhand S, Sun Y, Cassell R, Alpsoy A, Dykhuizen EC, van Rijn RM, Wendt MK, Krusemark C. Selection of DNA-encoded Libraries to Protein Targets Within and On Living Cells. Journal of the American Chemical Society. PMID 31613623 DOI: 10.1021/Jacs.9B08085  0.568
2019 Mores KL, Cummins BR, Cassell RJ, van Rijn RM. A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists. Frontiers in Pharmacology. 10: 407. PMID 31057409 DOI: 10.3389/fphar.2019.00407  0.775
2018 Cassell RJ, Mores KL, Zerfas BL, Mahmoud AH, Lill MA, Trader DJ, van Rijn RM. Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30591345 DOI: 10.1016/J.Euroneuro.2018.12.013  0.764
2018 Mores KL, Cassell RJ, van Rijn RM. Arrestin recruitment and signaling by G protein-coupled receptor heteromers. Neuropharmacology. PMID 30419245 DOI: 10.1016/j.neuropharm.2018.11.010  0.658
Show low-probability matches.